1. Home
  2. SRDX vs TRC Comparison

SRDX vs TRC Comparison

Compare SRDX & TRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • TRC
  • Stock Information
  • Founded
  • SRDX 1979
  • TRC 1843
  • Country
  • SRDX United States
  • TRC United States
  • Employees
  • SRDX N/A
  • TRC N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • TRC Real Estate
  • Sector
  • SRDX Health Care
  • TRC Finance
  • Exchange
  • SRDX Nasdaq
  • TRC Nasdaq
  • Market Cap
  • SRDX 415.4M
  • TRC 440.9M
  • IPO Year
  • SRDX 1998
  • TRC N/A
  • Fundamental
  • Price
  • SRDX $30.91
  • TRC $18.65
  • Analyst Decision
  • SRDX Buy
  • TRC
  • Analyst Count
  • SRDX 2
  • TRC 0
  • Target Price
  • SRDX $43.00
  • TRC N/A
  • AVG Volume (30 Days)
  • SRDX 92.6K
  • TRC 101.4K
  • Earning Date
  • SRDX 07-30-2025
  • TRC 08-05-2025
  • Dividend Yield
  • SRDX N/A
  • TRC N/A
  • EPS Growth
  • SRDX N/A
  • TRC 298.28
  • EPS
  • SRDX N/A
  • TRC 0.08
  • Revenue
  • SRDX $121,575,000.00
  • TRC $42,689,000.00
  • Revenue This Year
  • SRDX N/A
  • TRC $0.64
  • Revenue Next Year
  • SRDX $3.70
  • TRC N/A
  • P/E Ratio
  • SRDX N/A
  • TRC $231.75
  • Revenue Growth
  • SRDX N/A
  • TRC 7.04
  • 52 Week Low
  • SRDX $26.00
  • TRC $14.71
  • 52 Week High
  • SRDX $42.25
  • TRC $19.82
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 65.27
  • TRC 72.42
  • Support Level
  • SRDX $29.51
  • TRC $17.47
  • Resistance Level
  • SRDX $31.06
  • TRC $18.02
  • Average True Range (ATR)
  • SRDX 0.91
  • TRC 0.38
  • MACD
  • SRDX 0.18
  • TRC 0.15
  • Stochastic Oscillator
  • SRDX 86.61
  • TRC 98.00

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About TRC Tejon Ranch Co

Tejon Ranch Co is a diversified real estate development and agribusiness company committed to responsibly using its land and resources to meet the housing, employment, and lifestyle needs of Californians and create value for its shareholders. It has five segments namely Real Estate - Commercial/Industrial, Real Estate - Resort/Residential, Mineral Resources, Farming, and Ranch Operations.

Share on Social Networks: